Myriad Genetics buy Raymond James
Start price
25.02.25
/
50%
€11.40
Target price
25.02.26
€18.10
Performance (%)
-45.18%
Price
12.12.25
€6.15
Summary
This prediction is currently active. The BUY prediction by Raymond_James for Myriad Genetics is performing very badly with a performance of -45.18%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 0.820% | 0.820% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $19.00 price target on the stock, down previously from $27.00.
Ratings data for MYGN provided by MarketBeat